Virginia Tan

Internal Medicine

3181 SW Sam Jackson Park Rd
Portland, OR 97239

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Allogeneic Hematopoietic Cell Transplant Following Standard of Care Brexucabtagene Autoleucel in Adults with B-Cell Acute Lymphoblastic Leukemia: Results from the Real-World Outcomes Collaborative of Chimeric Antigen Receptor T in Adult Acute Lymphoblastic Leukemia.

Allogeneic Hematopoietic Cell Transplant Following Standard of Care Brexucabtagene Autoleucel in Adults with B-Cell Acute Lymphoblastic Leukemia: Results from the Real-World Outcomes Collaborative of Chimeric Antigen Receptor T in Adult Acute Lymphoblastic Leukemia.

Journal: Transplantation and cellular therapy

Published: April 21, 2026

Improved Outcomes with TKI Maintenance Following Brexucabtagene Autoleucel in Philadelphia-chromosome ALL.

Improved Outcomes with TKI Maintenance Following Brexucabtagene Autoleucel in Philadelphia-chromosome ALL.

Journal: Blood advances

Published: April 09, 2026

Improved outcomes with TKI maintenance after brexucabtagene autoleucel in Philadelphia chromosome ALL.

Improved outcomes with TKI maintenance after brexucabtagene autoleucel in Philadelphia chromosome ALL.

Journal: Blood advances

Published: April 09, 2026

Blinatumomab Nonresponse Correlates with Poor Survival After Brexucabtagene.

Blinatumomab Nonresponse Correlates with Poor Survival After Brexucabtagene.

Journal: Blood

Published: September 19, 2025

Blinatumomab nonresponse correlates with poor survival after brexucabtagene autoleucel in B-cell ALL.

Blinatumomab nonresponse correlates with poor survival after brexucabtagene autoleucel in B-cell ALL.

Journal: Blood

Published: September 19, 2025

CAR HEMATOTOX independently predicts outcomes after CD19 CAR-T therapy for acute lymphoblastic leukemia.

CAR HEMATOTOX independently predicts outcomes after CD19 CAR-T therapy for acute lymphoblastic leukemia.

Journal: Blood advances

Published: June 20, 2025

Impact of ABO compatibility on outcomes after allogeneic hematopoietic cell transplantation (HCT): increased risk of acute GVHD with ABO bidirectional mismatch, independent of traditional and emerging GVHD prophylaxis strategies.

Impact of ABO compatibility on outcomes after allogeneic hematopoietic cell transplantation (HCT): increased risk of acute GVHD with ABO bidirectional mismatch, independent of traditional and emerging GVHD prophylaxis strategies.

Journal: Cytotherapy

Published: May 24, 2025

Unveiling the complexities of catheter-related thrombosis: risk factors, preventive strategies, and management.

Unveiling the complexities of catheter-related thrombosis: risk factors, preventive strategies, and management.

Journal: Journal of thrombosis and thrombolysis

Published: January 31, 2025

Real-world performance of the CALGB 10403 regimen in young adults in the United States.

Real-world performance of the CALGB 10403 regimen in young adults in the United States.

Journal: Blood neoplasia

Published: January 02, 2025

The impact of hematology electronic consultations on the management of iron deficiency.

The impact of hematology electronic consultations on the management of iron deficiency.

Journal: European journal of haematology

Published: May 05, 2024

Desmopressin as a hemostatic and blood sparing agent in bleeding disorders.

Desmopressin as a hemostatic and blood sparing agent in bleeding disorders.

Journal: European journal of haematology

Published: May 23, 2022

Showing 1-11 of 11

Last Updated: 09/26/2026